ME/CFS brain fog is measurable on an MRI - new research links impaired glymphatic waste clearance to sleep disruption and ...
Alzheon, Inc., a clinical-stage biopharmaceutical company developing investigational therapies and diagnostic assays for ...
Phase 3 and Phase 2 Studies in APOE4/4 Alzheimer's Patients Show Favorable Safety, Low Risk for Brain Bleed and Edema (ARIA), and Neurovascular Protection. Long-Term Phase 3 and P ...
Tracking microstructural shifts in nerve tracts The research team identified these anatomical modifications using diffusion ...
Remepy, a pioneer in Hybrid Drugs™, today announced the publication of new mechanistic findings in npj Parkinson's Disease (Nature Portfolio). The study provides insight, for the first time, into ...
Abstract: Brain tumor segmentation and the accurate detection of tumor types remain significant challenges due to image variability, tumor heterogeneity, and boundary demarcation difficulties. These ...
Scientists at Rice University have produced the first full, dye-free molecular atlas of an Alzheimer’s brain. By combining laser-based imaging with machine learning, they uncovered chemical changes ...
Abstract: Spaceborne lidars are essential for monitoring Earth’s ecosystems, particularly in imaging forests, glaciers, and natural hazards. However, current satellite lidar systems, such as NASA’s ...
Alzheimer’s disease (AD) is responsible for many dementia-related deaths worldwide, and Mild Cognitive Impairment (MCI) is often its earliest clinical manifestation. Early detection of MCI is ...